Lushang Freda Pharmaceutical Co., Ltd.

Lushang Freda Pharmaceutical Co., Ltd. has recently experienced a change in its evaluation, reflecting shifts in its valuation metrics. Despite a premium P/E ratio and other significant financial indicators, the company faces challenges, including declining net sales and operating profit, highlighting its complex financial landscape.

Lushang Freda Pharmaceutical Co., Ltd. has recently adjusted its evaluation following a thorough analysis of its financial metrics and market conditions. The company has encountered significant challenges, including declining net sales and operating profit, alongside a high debt burden that raises concerns about its long-term sustainability.

Lushang Freda Pharmaceutical Co., Ltd. faced a notable decline in its stock price, contrasting with the broader market's performance. The company has experienced significant decreases over various time frames, including year-to-date and annual metrics, alongside challenges in financial performance and growth, raising concerns about its long-term viability.